secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001493152-23-009637
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences effects 1-for-12 reverse stock split effective March 31, 2023
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-12 ratio, effective 12:01 am on March 31, 2023.
- New CUSIP number 293602405; no fractional shares issued, cash paid in lieu.
- Exercise prices and shares of warrants, options, and RSUs adjusted proportionately.
- Series A Preferred Stock redeemed in connection with the reverse split.
- Stockholders approved the split on March 23, 2023; board set ratio at 1-for-12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223009637/0001493152-23-009637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223009637/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-009637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer